References
- Korelitz BI. An indicator of Crohn’s disease activity. A need unfulfilled. J Clin Gastroenterol 1986;8:220–2.
- DeDombal FT, Softly A. IOIBD report no 1: observer variation in calculating indices of severity and activity in Crohn’s disease. Gut 1987;28:474–81.
- Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964;1:89–92.
- Gomes P, Du Boulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986;27:92–5.
- Saverymuttu SH. Clinical remission in Crohn’s disease-assessment using faecal 111In granulocyte excretion. Digestion 1986;33:74–9.
- Modigliani R, Mary J-Y, Simon J-F, Cortot A, Soule J-C, Gendre J-P, et al. Clinical, biological and endoscopic picture of attacks of Crohn’s disease. Gastroenterology 1990;98:811–8.
- Becker W, Fischbach W, Weppler M, Mosl B, Jacoby G, Börner W. Radiolabelled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications. Nucl Med Commun 1988;9:693–701.
- Fagerhol MK, Andersson KB, Naess-Andresen CF, Brandtzaeg P, Dale I. Calprotectin (the L1 leukocyte protein). In: Smith VL, Dedman JR, editors. Stimulus response coupling: the role of intracellular calcium binding protein. Boca Raton (FL): CRC Press Inc; 1990. p. 187–210.
- Fagerhol MK. Nomenclature for proteins: is calprotein a proper name for the elusive myelomonocytic protein? J Clin Pathol Molec Pathol 1996;49:74–9.
- Røseth AG, Fagerhol MK, Aadland E, Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. Scand J Gastroenterol 1992;27:793–8.
- Odink K, Cerletti N, Bruggen J, Clerc RG, Tarscay L, Zwadlo G, et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987;330:80–2.
- Wilkinson MM, Busuttil A, Hayward C, Brock DJ, Dorin JR, van Heyningen V. Expression pattern of two related cystic fibrosis-associated calcium-binding protein in normal and abnormal tissues. J Cell Sci 1988;91:221–30.
- Wilson GB, Jahn TL, Fonseca JR. Demonstration of serum protein differences in cystic fibrosis by isoelectic focussing in thin-layer polyacrylamid gels. Clin Chim Acta 1973;49:79–85.
- Osman S, Danpure HJ. The use of 2-(18F)fluoro-2-deoxy-D- glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B 1992;19:183–90.
- Crama-Bohbouthg E, Arndt JW, Pena AS, Verspaget HW, Tjon A, Tham RTO, et al. Value of indium-111 granulocyte scintigraphy in the assessment of Crohn’s disease of the small intestine: prospective investigation. Digestion 1988;40: 227–36.
- Park RHR, McKillop JH, Duncan A, MacKenzie JF, Russell RI. Can 111Indium autologous mixed leucocyte scanning accurately assess disease extent and activity in Crohn’s disease? Gut 1988;29: 821–5.
- Adeyemi EO, Hodgson HJF. Faecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol 1992;27:139–42.
- Uchida K, Matsuse R, Tomita S, Sugi K, Saitho O, Ohshiba S. Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancer. Clin Biochem 1994;27:259–64.
- R0seth AG, Aadland E, Jahnsen J, Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997;57:176–80.
- Løser C, Møllgaard A, Fölsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut 1996;39:580–6.
- Thorsgaard Pedersen N, Halgreen H, Worning H. Estimation of the 3-day faecal excretion and fat concentration as a differential test of malabsortion and maldigestion. Scand J Gastroentrol 1987;22: 91–6.
- Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 199435669–74
- Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P, Scott H. Cytokine profiles differ in newly recruited and resident subset of mucosal macrophages from inflammatory bowel disease. Gastroenterology 1997;112:1493–505.
- Cellier C, Sahmoud T, Froguel E, Adenis A, Belaiche J, Bretagne J-F, et al. Correlation between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn’s disease. A prospective multicentre study of 122 cases. Gut 1994;35: 231–5.